Recently, elevated FGF23 levels were found to be associated with adverse outcomes, such as vascular calcification [22], left ventricular hypertrophy [23], cardiovascular events [24], and increased mortality [25, 26]. This evidence concerns the gene FGF23 and left ventricular hypertrophy.